Concentra Group Holdings delivered robust performance in the second quarter of 2025, with revenue increasing by 15.2% to $550.8 million and Adjusted EBITDA growing by 13.2% to $115.0 million. The company saw a 9.5% increase in patient visits per day and a 4.4% rise in revenue per visit. Net income was $46.2 million, and Adjusted EPS was $0.37. The company also successfully integrated recent acquisitions, expanding its network to over 1,000 locations.
Revenue increased by 15.2% to $550.8 million in Q2 2025, up from $477.9 million in Q2 2024.
Adjusted EBITDA grew by 13.2% to $115.0 million, compared to $101.6 million in the prior year's quarter.
Patient visits per day increased by 9.5% to 55,005, and revenue per visit rose by 4.4% to $145.92.
The company expanded its footprint to 628 occupational health centers and 406 onsite health clinics, totaling over 1,000 locations, partly due to the acquisition of Pivot Onsite Innovations.
Concentra raised its financial guidance for the full year 2025, expecting higher revenue and Adjusted EBITDA, while maintaining capital expenditure and net leverage ratio targets.